BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8574166)

  • 1. Fatal bone marrow necrosis following fludarabine administration in a patient with indolent lymphoma.
    Aboulafia DM; Demirer T
    Leuk Lymphoma; 1995 Sep; 19(1-2):181-4. PubMed ID: 8574166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
    Palomera L; Azaceta G; Varo MJ; Soria J; Gutierrez M
    Haematologica; 1998 Nov; 83(11):1045-6. PubMed ID: 9864929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludarabine phosphate therapy of non-Hodgkin's lymphoma.
    Hochster H; Cassileth P
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):63-5. PubMed ID: 1699284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.
    Decaudin D; Bosq J; Tertian G; Nedellec G; Bennaceur A; Venuat AM; Bayle C; Carde P; Bendahmane B; Hayat M; Munck JN
    J Clin Oncol; 1998 Feb; 16(2):579-83. PubMed ID: 9469344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma.
    Ogawa Y; Hotta T; Tobinai K; Watanabe T; Sasaki Y; Minami H; Morishima Y; Ogura M; Seriu T
    Ann Oncol; 2006 Feb; 17(2):330-3. PubMed ID: 16275653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
    Tobinai K; Watanabe T; Ogura M; Morishima Y; Ogawa Y; Ishizawa K; Minami H; Utsunomiya A; Taniwaki M; Terauchi T; Nawano S; Matsusako M; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Hayashi M; Seriu T; Hotta T
    J Clin Oncol; 2006 Jan; 24(1):174-80. PubMed ID: 16330664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow necrosis in adult acute leukemia and non-Hodgkin's lymphoma.
    Forrest DL; Mack BJ; Nevill TJ; Couban SH; Zayed E; Foyle A
    Leuk Lymphoma; 2000 Aug; 38(5-6):627-32. PubMed ID: 10953985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
    Redman JR; Cabanillas F; Velasquez WS; McLaughlin P; Hagemeister FB; Swan F; Rodriguez MA; Plunkett WK; Keating MJ
    J Clin Oncol; 1992 May; 10(5):790-4. PubMed ID: 1373760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
    Hagenbeek A; Eghbali H; Monfardini S; Vitolo U; Hoskin PJ; de Wolf-Peeters C; MacLennan K; Staab-Renner E; Kalmus J; Schott A; Teodorovic I; Negrouk A; van Glabbeke M; Marcus R
    J Clin Oncol; 2006 Apr; 24(10):1590-6. PubMed ID: 16575010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
    Gershanovich ML; Zaritskiń≠ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
    Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
    Foran JM; Oscier D; Orchard J; Johnson SA; Tighe M; Cullen MH; de Takats PG; Kraus C; Klein M; Lister TA
    J Clin Oncol; 1999 May; 17(5):1574-9. PubMed ID: 10334546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstr√∂m's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
    J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow necrosis with dyspnea in a patient with malignant lymphoma and plasma levels of thrombomodulin, tumor necrosis factor-alpha, and D-dimer.
    Seki Y; Koike T; Yano M; Aoki S; Hiratsuka M; Fuse I; Aizawa Y
    Am J Hematol; 2002 Jul; 70(3):250-3. PubMed ID: 12111773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of follicular lymphoma with MYC gene abnormalities that presented with bone marrow necrosis.
    Miyazawa Y; Takei H; Kobayashi N; Akashi N; Sairenji Y; Sugisaki M; Naito C; Ishikawa T; Shimizu H; Ishizaki T; Yokohama A; Tsukamoto N; Yoshida Y; Matsumura N; Takayama Y; Handa H
    J Clin Exp Hematop; 2022 Dec; 62(4):208-216. PubMed ID: 36261333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature.
    Paydas S; Ergin M; Baslamisli F; Yavuz S; Zorludemir S; Sahin B; Bolat FA
    Am J Hematol; 2002 Aug; 70(4):300-5. PubMed ID: 12210811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Chun HG; Leyland-Jones B; Cheson BD
    J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine nucleoside analogs in indolent non-Hodgkin's lymphoma.
    Cabanillas F
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):13-5. PubMed ID: 10887639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow necrosis in a girl with Hodgkin's disease.
    Lackner H; Strenger V; Sovinz P; Beham-Schmid C; Pilhatsch A; Benesch M; Schwinger W; Ulreich R; Schmidt S; Urban C
    Support Care Cancer; 2012 Sep; 20(9):2231-4. PubMed ID: 22773298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New chemotherapeutic agents for non-Hodgkin's lymphomas.
    Cheson BD
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1027-51. PubMed ID: 1718938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.